Subscribe for stories that matter!
Warrington-based biopharmaceutical firm Windtree Therapeutics is entering a multimillion-dollar licensing deal with a Chinese drug company for its three new cardiovascular disease drug…
Before we send you to this site, please subscribe to our daily newsletter.
